Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03692624 · ClinicalTrials.gov registry record · NA
Use of Heart Rate Variability (HRV) Biofeedback for Cancer Survivors
A NA study, sponsored by Prisma Health-Upstate.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT03692624 is a NA study that has completed, run by Prisma Health-Upstate. The registered enrollment target is 34 participants.
The verdict
NCT03692624, a NA study, has completed, sponsored by Prisma Health-Upstate.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Heart rate variability biofeedback (HRV-B) is a complementary, non-pharmacologic therapy that is being tested to see if it can help cancer survivors reduce their symptoms of pain, stress, insomnia, fatigue, or depression. HRV-B is an interactive procedure in which participants relax and breathe regularly while watching the a computer screen. The computer screen provides feedback that helps people increase their heart rate variability.
Interventions
- BEHAVIORAL Biofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2015-05-10 |
| Est. Completion | 2020-02-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03692624
The ClinicalTrials.gov registry entry for NCT03692624 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prisma Health-Upstate, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biofeedback is the first listed.
NCT03692624 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03692624 about?
NCT03692624 is a clinical study titled "Use of Heart Rate Variability (HRV) Biofeedback for Cancer Survivors". Heart rate variability biofeedback (HRV-B) is a complementary, non-pharmacologic therapy that is being tested to see if it can help cancer survivors reduce their symptoms of pain, stress, insomnia, fatigue, or depression. HRV-B is an interactive procedure in which participants relax and breathe regu...
What is the current status of trial NCT03692624?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2015-05-10. Estimated completion is 2020-02-07.
What interventions are being tested in trial NCT03692624?
The interventions under investigation include: Biofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT03692624?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.